Advertisement

Topics

Japan’s Takeda and Cardurion partner to develop new heart disease treatments

19:00 EDT 3 Aug 2017 | Pharmaceutical Technology

Japan-based Takeda Pharmaceutical has entered a partnership with Cardurion Pharmaceuticals to develop new and advanced therapeutics for the treatment of cardiovascular diseases.

Original Article: Japan’s Takeda and Cardurion partner to develop new heart disease treatments

NEXT ARTICLE

More From BioPortfolio on "Japan’s Takeda and Cardurion partner to develop new heart disease treatments"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...